4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000054
Director sold 35,000 shares at an average $70.13 ($2,454,382)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Dambkowski Carl · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-11 | Sale : show line 1 in the form 10b5-1 | −22,417 | $70.13 | $1,572,201 | 51,326 | D |
| 2026-06-12 | Sale : show line 2 in the form 10b5-1 | −12,583 | $70.11 | $882,182 | 38,743 | D |
| Open-market sales · 35,000 sh · avg $70.13 · $2,454,382 | ||||||
Loading xslF345X06/form4.xml…